2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1669630109 MD
Verify on CMS →

ANITA RAGHUWANSHI, MD

Endocrinology, Diabetes & Metabolism Physician in CAPE MAY COURT HOUSE, New Jersey. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
9K
Medicare Part D claims · 1K beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
56%
generic claims · 44% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
79.3818/100
▼ 4 pts below national avg 83.1 · [object Object]
Industry payments
$2.6K
67 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

ANITA RAGHUWANSHI, MD reported a CMS MIPS final score of 79.3818/100 — below the 83.1 national average — and filed 9,055 Medicare Part D claims in 2023.

79.3818/100
MIPS score · -4 vs avg
9K
Part D claims, 2023
56%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

ANITA RAGHUWANSHI, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

79 30th percentile higher than 30% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). This entry sits in this band. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

ANITA RAGHUWANSHI, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about ANITA RAGHUWANSHI, MD?

Near national average

NPI registry status

Active

Issued 05/31/2008

NPI 1669630109

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,852 US NPIs in this specialty

Medicare Part D claims

9,055 243% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

MIPS final score

79.3818/100 3.718199999999996% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in New Jersey

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among New Jersey providers

New Jersey providers

Endocrinology, Diabetes & Metabolism Physician share within New Jersey

1. Endocrinology, Diabetes & Metabolism Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Endocrinology, Diabetes & Metabolism Physician share within New Jersey

Medicare quality performance — MIPS

ANITA RAGHUWANSHI, MD's 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average

Near national average
MIPS Final Score
79.3818/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 79.3818/100 vs national avg 83.1

0%100%National avg83%79.4%
MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 79.3818/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ANITA RAGHUWANSHI, MD appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding MD credentials at 11 VILLAGE DR, CAPE MAY COURT HOUSE, NJ, 08210, with a listed phone of (609) 465-2273. NPI 1669630109 was issued on 05/31/2008. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what RAGHUWANSHI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 9,055 prescription claims written by this provider, covering 1,008 Medicare beneficiaries and totaling roughly $4.8 million in drug spend, split 44% brand-name and 56% generic by claim count, with an opioid prescribing rate of 0.1%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 79.3818/100 for the 2023 performance year (Quality 74.8034, Cost 58.1358), compared with the national average of 83.1.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

11 VILLAGE DR
CAPE MAY COURT HOUSE, NJ 08210

Provider Details

NPI 1669630109
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials MD
Gender Female
NPI Issued 05/31/2008

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

79.3818
Final Score
Avg: 83.1
74.8034
Quality
58.1358
Cost
98
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where ANITA RAGHUWANSHI, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

COOPER CARE ALLIANCE, PC
CAPE MAY COURT HOUSE, NJ

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ANITA RAGHUWANSHI, MD. Source: openpaymentsdata.cms.gov.

Total received

$2.6K

Largest payer

Tandem Diabetes Care, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Above average

ANITA RAGHUWANSHI, MD — brand share 44.0%
Specialty average (est.)

44% brand-name claims vs 56% generic, on 9,055 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

9,055
Total Claims
$4.8M
Total Drug Cost
1,008
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
23,179
Total Day Supply
691,687
Brand vs Generic
44% brand / 56% generic
Brand Drug Cost
$4.6M
Generic Drug Cost
$150K
Opioid Claims
12 (0.1% rate)
Antibiotic Claims
15

Patient Demographics

Average Patient Age
72.0 years
Avg HCC Risk Score
1.72
Gender Split
62% female / 38% male
Age Distribution
<65: 127, 65-74: 486, 75-84: 323, 85+: 72

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What ANITA RAGHUWANSHI, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Levothyroxine Sodium
872
Pioglitazone Hcl
537
Jardiance
Empagliflozin
392
Metformin Hcl
385
Synthroid
Levothyroxine Sodium
369
Trulicity
Dulaglutide
325
Metformin Hcl Er
Metformin Hcl
321
Ozempic
Semaglutide
282
Rosuvastatin Calcium
269
Repaglinide
226

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How ANITA RAGHUWANSHI, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

ANITA RAGHUWANSHI, MD's 9,055 claims are above the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in New Jersey

Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as RAGHUWANSHI.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ANITA RAGHUWANSHI, MD's specialty?
ANITA RAGHUWANSHI, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in CAPE MAY COURT HOUSE, New Jersey. Credentials: MD.
How much does ANITA RAGHUWANSHI, MD prescribe under Medicare Part D?
In 2023, ANITA RAGHUWANSHI, MD wrote 9,055 Medicare Part D claims totaling $4.8M in drug costs for 1,008 beneficiaries.
What is ANITA RAGHUWANSHI, MD's Medicare quality score?
ANITA RAGHUWANSHI, MD has a CMS MIPS Final Score of 79.3818/100 (Quality: 74.8034, Cost: 58.1358). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is ANITA RAGHUWANSHI, MD located?
ANITA RAGHUWANSHI, MD is located at 11 VILLAGE DR, CAPE MAY COURT HOUSE, NJ, 08210. Phone: (609) 465-2273.
What is ANITA RAGHUWANSHI, MD's NPI number?
ANITA RAGHUWANSHI, MD's National Provider Identifier (NPI) is 1669630109, issued on 05/31/2008.
Does ANITA RAGHUWANSHI, MD prescribe more brand-name or generic drugs?
ANITA RAGHUWANSHI, MD's prescribing is 44% brand-name and 56% generic drugs by claim count, with $4.6M in brand drug costs.
Does ANITA RAGHUWANSHI, MD prescribe opioids?
Yes, ANITA RAGHUWANSHI, MD had 12 opioid claims in 2023 with an opioid prescribing rate of 0.1%.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does ANITA RAGHUWANSHI, MD prescribe most often?
Based on 2023 Medicare Part D data, ANITA RAGHUWANSHI, MD's most frequently prescribed drugs include Levothyroxine Sodium, Pioglitazone Hcl, Jardiance. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ANITA RAGHUWANSHI, MD accept Medicare?
ANITA RAGHUWANSHI, MD appears in CMS Medicare data with 9,055 Part D claims and 1,008 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ANITA RAGHUWANSHI, MD's credentials?
ANITA RAGHUWANSHI, MD's NPI is 1669630109 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology